XML 22 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 28, 2024
Dec. 30, 2023
Current assets:    
Cash and cash equivalents $ 194,606 $ 276,771
Trade receivables and contract assets, net of allowances for credit losses of $18,301 and $25,722, respectively 720,915 780,375
Inventories 278,544 380,259
Prepaid assets 103,210 87,879
Other current assets 105,796 83,378
Total current assets 1,403,071 1,608,662
Property, plant and equipment, net 1,604,014 1,639,741
Venture capital and strategic equity investments 218,350 243,811
Operating lease right-of-use assets, net 412,490 394,029
Goodwill 2,846,608 3,095,045
Intangible assets, net 723,400 864,051
Deferred tax assets 42,179 40,279
Other assets 278,233 309,383
Total assets 7,528,345 8,195,001
Current liabilities:    
Accounts payable 140,337 168,937
Accrued compensation 179,418 213,290
Deferred revenue 248,322 241,820
Accrued liabilities 232,010 227,825
Other current liabilities 194,014 203,210
Total current liabilities 994,101 1,055,082
Long-term debt, net and finance leases 2,240,205 2,647,147
Operating lease right-of-use liabilities 483,789 419,234
Deferred tax liabilities 106,960 191,349
Other long-term liabilities 195,212 223,191
Total liabilities 4,020,267 4,536,003
Commitments and contingencies (Notes 2, 11, 13, and 18)
Redeemable noncontrolling interests 41,126 56,722
Equity:    
Preferred stock, $0.01 par value; 20,000 shares authorized; no shares issued and outstanding 0 0
Common stock, $0.01 par value; 120,000 shares authorized; 51,141 shares issued and outstanding as of December 28, 2024 and 51,338 shares issued and outstanding as of December 30, 2023 511 513
Additional paid-in capital 1,966,237 1,905,578
Retained earnings 1,812,100 1,887,218
Treasury stock, at cost, zero shares as of December 28, 2024 and December 30, 2023 0 0
Accumulated other comprehensive loss (317,345) (196,427)
Total Charles River Laboratories International, Inc. equity 3,461,503 3,596,882
Nonredeemable noncontrolling interest 5,449 5,394
Total equity 3,466,952 3,602,276
Total liabilities, redeemable noncontrolling interests and equity $ 7,528,345 $ 8,195,001